Puma Biotechnology Narrows FY2026 Sales Guidance from $224.000M-$231.000M to $224.000M-$227.000M
Benzinga Newsdesk 1 hour ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) narrows FY2026 sales outlook from $224.000 million-$231.000 million to $224.000 million-$227.000 million.
Puma Biotechnology (NASDAQ:PBYI) narrows FY2026 sales outlook from $224.000 million-$231.000 million to $224.000 million-$227.000 million.